Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Non-Current Assets (2020 - 2026)

Journey Medical filings provide 6 years of Non-Current Assets readings, the most recent being $27.7 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 13.55% to $27.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $117.4 million, a 33.06% increase, with the full-year FY2025 number at $27.7 million, down 13.55% from a year prior.
  • Non-Current Assets hit $27.7 million in Q4 2025 for Journey Medical, down from $28.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $35.1 million in Q1 2023 to a low of $12.8 million in Q4 2021.
  • Median Non-Current Assets over the past 5 years was $27.6 million (2022), compared with a mean of $25.3 million.
  • Biggest five-year swings in Non-Current Assets: surged 114.85% in 2022 and later tumbled 44.33% in 2024.
  • Journey Medical's Non-Current Assets stood at $12.8 million in 2021, then skyrocketed by 114.85% to $27.5 million in 2022, then dropped by 25.79% to $20.4 million in 2023, then soared by 57.21% to $32.1 million in 2024, then fell by 13.55% to $27.7 million in 2025.
  • The last three reported values for Non-Current Assets were $27.7 million (Q4 2025), $28.8 million (Q3 2025), and $29.9 million (Q2 2025) per Business Quant data.